Regal Assets Analytics

OGEN

Gritstone, BioXcel Expect to Report Catalysts in July 2020; 2Q SanaCurrents Update

By |2020-10-20T14:21:50-04:00July 6th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: , , , , , , , , , , , , , , , , |

Gritstone Oncology (NASDAQ:GRTS) plans to hold a conference call and [...]

Acceleron Hits Second Catalyst; Eight More SanaCurrents Catalysts Expected For 2Q 2020

By |2020-04-15T11:07:58-04:00April 15th, 2020|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: , , , , , , , , , |

Onconova Coverage suspended, Oragenics falls short in Phase II trial.   [...]

Oragenics, Inc Therapeutics (OGEN) Probability Sentiment

By |2020-04-19T10:26:17-04:00February 15th, 2020|Categories: Bill Langbein, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: , |

Oragenics Inc. (NYSE:OGEN) Probability Sentiment [...]